Citigroup Inc Nuvasive Inc Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$36.71 - $44.15 $401,974 - $483,442	-10,950 Reduced 2.77%	384,383 $16 Million
Q1 2023 May 11, 2023	BUY	$36.81 - $48.12 $13.3 Million - $17.4 Million	360,952 Added 1049.86%	395,333 $16.3 Million
Q4 2022 Feb 09, 2023	SELL	$35.68 - $44.71 $38.4 Million - $48.1 Million	-1,075,081 Reduced 96.9%	34,381 $1.42 Million
Q3 2022 Nov 10, 2022	BUY	$42.51 - $54.02 $229,681 - $291,870	5,403 Added 0.49%	1,109,462 $48.6 Million
Q2 2022 Aug 10, 2022	BUY	$46.84 - $59.75 $45.7 Million - $58.3 Million	975,455 Added 758.5%	1,104,059 $54.3 Million

Q1 2022 May 12, 2022	BUY	$48.09 - $57.79 $5.16 Million - $6.19 Million	107,197 Added 500.76%	128,604 $7.29 Million
Q4 2021 Feb 10, 2022	BUY	$47.19 - $62.68 $605,966 - $804,873	12,841 Added 149.91%	21,407 $1.12 Million
Q3 2021 Nov 10, 2021	BUY	$56.91 - $67.81 $487,491 - $580,860	8,566 New	8,566 $514,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.